TABLE 1.
Sample no. (type) | Dilution | Copy no.a | Cp | Genotype | Tm | ΔTm |
---|---|---|---|---|---|---|
1 (CSF) | 100 | 50,679 | 21.70 | HSV-1 | 53.33 | −0.90 |
10−1 | 3,320 | 25.67 | HSV-1 | 53.21 | −1.02 | |
10−2 | 369 | 28.87 | HSV-1 | 53.29 | −0.94 | |
10−3 | 42 | 32.04 | HSV-1 | 53.37 | −0.86 | |
10−4 | 3 | 35.79 | HSV-1 | 53.46 | −0.77 | |
2 (CSF) | 100 | 27283 | 23.97 | HSV-2 | 67.03 | 0.81 |
10−1 | 2,775 | 27.54 | HSV-2 | 66.47 | 0.25 | |
10−2 | 282 | 31.11 | HSV-2 | 66.18 | −0.04 | |
10−3 | 53 | 33.72 | UKNb | 65.70 | −0.52 | |
10−4 | 3 | 38.57 | UKN | 61.52 | −4.70c | |
3 (Genital, penis) | 100 | 4,602 | 26.75 | HSV-2 | 66.67 | 0.45 |
10−1 | 423 | 30.48 | HSV-2 | 66.40 | 0.18 | |
10−2 | 35 | 34.37 | HSV-2 | 65.91 | −0.31 | |
10−3 | 4 | 37.84 | UKN | 63.67 | −2.55c | |
10−4 | 1 | >40.00 | UKN | 61.02 | −5.20c | |
4 (Genital, vulva) | 100 | 4,235 | 26.88 | HSV-2 | 66.56 | 0.34 |
10−1 | 386 | 30.62 | HSV-2 | 66.16 | −0.06 | |
10−2 | 46 | 33.95 | UKN | 65.77 | −0.45 | |
10−3 | 9 | 36.48 | UKN | 63.01 | −3.21c | |
5 (Oral, lip) | 100 | 2,176 | 27.92 | HSV-2 | 66.40 | 0.18 |
10−1 | 323 | 30.90 | HSV-2 | 66.10 | −0.12 | |
10−2 | 56 | 33.63 | UKN | 65.69 | −0.53 | |
10−3 | 1 | >40.00 | UKN | 60.07 | −6.15c | |
6 (Oral, tongue) | 100 | 381 | 30.64 | HSV-2 | 66.17 | −0.05 |
10−1 | 66 | 33.37 | HSV-2 | 65.36 | −0.86 | |
10−2 | 9 | 36.48 | UKN | 63.09 | −3.13c |
The copy number was estimated in relation to the copy number on a standard curve generated with plasmid-borne controls.
UKN, unknown; the software was unable to genotype the specimens.
Compared to the Tm values for the HSV-1- or HSV-2-positive control, the ΔTm values were above the acceptable variation (±2.5°C) recommended by the manufacturer.